Bristol-Myers Squibb Company (BMY) Release: Giovanni Caforio, M.D., Appointed Chief Operating Officer And Elected To Board Of Directors
6/9/2014 11:19:05 AM
Bristol-Myers Squibb Company (NYSE:BMY) today announced that Giovanni Caforio, M.D., has been appointed chief operating officer and elected to Bristol-Myers Squibb’s Board of Directors, effective June 5, 2014. He will continue to report to Lamberto Andreotti, chief executive officer. In addition to his current responsibilities as chief commercial officer, Caforio will add leadership responsibility for the company-wide functions of Enterprise Services and Global Manufacturing & Supply.
Help employers find you! Check out all the jobs and post your resume.
comments powered by